Susanta Samajdar
31Patents
6h-index
45Co-inventors
65Inventor score
Filing activity: Nov 1, 2011 → Dec 23, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9732095B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 18 | Active |
| US10160753B2 | Indazole compounds as IRAK4 inhibitors | Chemistry; Metallurgy | 10 | Active |
| US10047104B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10640517B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US10479775B1 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10399958B2 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10336697B2 | Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors | Chemistry; Metallurgy | 6 | Active |
| US10995100B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11419875B2 | Compounds and compositions for treating hematological disorders | Human Necessities | 4 | Active |
| US9796683B2 | Tetrasubstituted alkene compounds and their use | Chemistry; Metallurgy | 4 | Active |
| US9067920B2 | Compounds useful for inhibiting Chk1 | Chemistry; Metallurgy | 3 | Active |
| US11691987B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US11865114B2 | Method for treating diseases using SMARCA2/4 degraders | Chemistry; Metallurgy | 2 | Active |
| US10077259B2 | Bicyclic heterocyclic derivatives as bromodomain inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10689347B2 | Substituted heterocyclyl derivatives as CDK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10906885B2 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11578052B2 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US11174232B2 | Substituted heterocyclyl derivatives as CDK inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11981685B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9227969B2 | Compounds and compositions as inhibitors of MEK | Human Necessities | 1 | Active |
| US12428379B2 | Acylsulfonamide KAT6A inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10894786B2 | Substituted pyrazole derivatives as selective CDK12/13 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12331023B2 | Substituted heterocyclyl derivatives as CDK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12371426B2 | Pyridazine derivatives as SMARCA2/4 degraders | Chemistry; Metallurgy | 0 | Active |
| US11186576B2 | Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.